NO982467L - Acylerte enolderivater av <alfa>-ketoestere og <alfa>-ketoamider - Google Patents

Acylerte enolderivater av <alfa>-ketoestere og <alfa>-ketoamider

Info

Publication number
NO982467L
NO982467L NO982467A NO982467A NO982467L NO 982467 L NO982467 L NO 982467L NO 982467 A NO982467 A NO 982467A NO 982467 A NO982467 A NO 982467A NO 982467 L NO982467 L NO 982467L
Authority
NO
Norway
Prior art keywords
alfa
ketoamides
ketoesters
enol derivatives
acylated enol
Prior art date
Application number
NO982467A
Other languages
English (en)
Other versions
NO982467D0 (no
Inventor
Norton Paul Peet
Joseph Paul Burkhart
Shujaath Mehdi
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of NO982467D0 publication Critical patent/NO982467D0/no
Publication of NO982467L publication Critical patent/NO982467L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO982467A 1995-12-01 1998-05-29 Acylerte enolderivater av <alfa>-ketoestere og <alfa>-ketoamider NO982467L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56619695A 1995-12-01 1995-12-01
PCT/US1996/017752 WO1997020856A1 (en) 1995-12-01 1996-11-04 ACYLATED ENOL DERIVATIVES OF α-KETOESTERS AND α-KETOAMIDES

Publications (2)

Publication Number Publication Date
NO982467D0 NO982467D0 (no) 1998-05-29
NO982467L true NO982467L (no) 1998-08-03

Family

ID=24261904

Family Applications (1)

Application Number Title Priority Date Filing Date
NO982467A NO982467L (no) 1995-12-01 1998-05-29 Acylerte enolderivater av <alfa>-ketoestere og <alfa>-ketoamider

Country Status (20)

Country Link
EP (1) EP0863915B1 (no)
JP (1) JP2000502073A (no)
KR (1) KR19990071822A (no)
CN (1) CN1127512C (no)
AR (1) AR005240A1 (no)
AT (1) ATE189457T1 (no)
AU (1) AU705819B2 (no)
CA (1) CA2239159C (no)
DE (1) DE69606552T2 (no)
ES (1) ES2144788T3 (no)
GR (1) GR3033205T3 (no)
HU (1) HUP9902417A3 (no)
IL (1) IL124499A (no)
MX (1) MX9804265A (no)
NO (1) NO982467L (no)
NZ (1) NZ322731A (no)
PT (1) PT863915E (no)
TW (1) TW419482B (no)
WO (1) WO1997020856A1 (no)
ZA (1) ZA969889B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998001133A1 (en) * 1996-07-08 1998-01-15 Yamanouchi Pharmaceutical Co., Ltd. Bone resorption inhibitors
ES2221227T3 (es) * 1997-11-24 2004-12-16 MERCK &amp; CO., INC. Derivados sustituidos de beta-alanina como inhibidores de la adhesion celular.
US6645939B1 (en) 1997-11-24 2003-11-11 Merck & Co., Inc. Substituted β-alanine derivatives as cell adhesion inhibitors
US20060252698A1 (en) * 2005-04-20 2006-11-09 Malcolm Bruce A Compounds for inhibiting cathepsin activity
KR101012313B1 (ko) * 2008-06-10 2011-02-09 서울대학교산학협력단 염증질환 치료제

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378457A (en) * 1981-12-24 1995-01-03 Virogenetics Corporation Interferon sensitive recombinant poxvirus vaccine
JPH06504547A (ja) * 1990-12-28 1994-05-26 ジョージア・テック・リサーチ・コーポレーション ペプチドケトアミド、ケト酸およびケトエステル

Also Published As

Publication number Publication date
CN1203602A (zh) 1998-12-30
TW419482B (en) 2001-01-21
ES2144788T3 (es) 2000-06-16
MX9804265A (es) 1998-09-30
ZA969889B (en) 1997-06-17
HUP9902417A2 (hu) 1999-11-29
DE69606552T2 (de) 2000-09-14
GR3033205T3 (en) 2000-08-31
ATE189457T1 (de) 2000-02-15
CN1127512C (zh) 2003-11-12
CA2239159C (en) 2002-09-10
PT863915E (pt) 2000-05-31
AU7669796A (en) 1997-06-27
WO1997020856A1 (en) 1997-06-12
NO982467D0 (no) 1998-05-29
IL124499A (en) 2003-05-29
NZ322731A (en) 1999-10-28
EP0863915B1 (en) 2000-02-02
KR19990071822A (ko) 1999-09-27
CA2239159A1 (en) 1997-06-12
AR005240A1 (es) 1999-04-28
EP0863915A1 (en) 1998-09-16
HUP9902417A3 (en) 2000-11-28
JP2000502073A (ja) 2000-02-22
AU705819B2 (en) 1999-06-03
DE69606552D1 (de) 2000-03-09
IL124499A0 (en) 1998-12-06

Similar Documents

Publication Publication Date Title
DE69608448D1 (de) Reduktion des biobewuchses
DE69617652D1 (de) Verminderung des haarwuchses
NO974701D0 (no) Syntese av tale-bölgeformer
NO934547D0 (no) Oral behandling av Helicobacter-in-feksjon
FI934874A0 (fi) Stereoselektiv reducering av ketoner
DE69413815D1 (de) Inhibierung des Haarwuchses
ITMI931114A1 (it) Complesso costruttivo di apparecchio depuratore e sterilizzatore d&#39;acqua
BR9611475A (pt) 5-aminoisotiaz is acilados
DE69636792D1 (de) Verwendung von l-carnitine und acyl derivaten zur senkung des ceramidspiegels
FI973591A0 (fi) Nya syntetiserade kryptofysiner
BR9607427A (pt) Inibiçao de angiogêne usando interleucina 12
FR2731885B1 (fr) Installation d&#39;etageres demontables
NO960414L (no) Anvendelse av fenylcykloheksylkarboksylsyreamider
NO982467D0 (no) Acylerte enolderivater av &lt;alfa&gt;-ketoestere og &lt;alfa&gt;-ketoamider
BR9306359A (pt) Azocorantes aplicação do azocorante e modificação cristalina
ITRM940210A1 (it) Procedimento per la purificazione di soluzioni di policarbunati e di poliestercarbonati
NO964685L (no) Isomering av equilin
KR970026816U (ko) 쇼케이스의 도어착탈구조
KR970024898U (ko) 냉장고의 루버와 루버절연물
FI954952A0 (fi) Foerfarande och anordning vid producering av kylningseffekt
DK0863915T3 (da) Acylerede enolderivater af alfa-ketoestere og alfa-ketoamider
IT1279769B1 (it) Sistema meccanico per la variazione continua di tinta e luminosita&#39;
KR970006700U (ko) 쇼케이스의 냉각기 취부구
KR970014677U (ko) 냉장고의 루버와 루버절연물 구조
LV11100A (lv) Miksto mebelu transformacijas mehanismi

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application